ESTOCIN owner Contact Information online
from RANBAXY LABORATORIES LIMITED
ESTOCIN
US serial number:85071525
Application filling date:Jun. 25, 2010
Register:Principal
Mark type:Trademark
Status:Abandoned because no Statement of Use or Extension Request timely filed after Notice of Allowance was issued. To view all documents in this file, click on the Trademark Document Retrieval link at the top of this page.
Status date:Feb. 24, 2014
Publication date:Nov. 23, 2010
Abandoned date:Feb. 24, 2014
Standard character claim:Yes. The mark consists of standard characters without claim to any particular font style, size, or color.
Mark drawing type:4 - STANDARD CHARACTER MARK
Goods and services:For: Pharmaceutical and medicinal preparation for treatment of dermatological conditions
International Class(es): 005- Primary Class
U.S Class(es): 006,018,044,046,051,052
Class Status: ACTIVE
Basis: 1(b)
Services:Pharmaceutical and medicinal preparation for treatment of dermatological conditions
Current owner owner name:RANBAXY LABORATORIES LIMITED
Current owner owner address:Head Office: 12 Floor, Devika Tower
06, Nehru Place
New Delhi, Delhi
INDIA
110019
Current owner legal entity type:CORPORATION
Current owner state or country:INDIA
Attorney name:James DeYonker
Attorney email:general.ip.mailbox@ranbaxy.com
Attorney docket number:RTM-225
Attorney email authorized:Yes
Correspondent name address:JAMES DEYONKER
RANBAXY INC.
600 COLLEGE RD E STE 2100
PRINCETON,
NEW JERSEY
UNITED STATES
08540-6636
Correspondent phone:609-720-5394
Correspondent email:general.ip.mailbox@ranbaxy.com
Correspondent fax:609-514-9779
Correspondent email authorized:Yes
Trademark staff tm attorney:CARLYLE, SHAUNIA P
Trademark staff law office assigned ESTOCIN:LAW OFFICE 110
Latest trademarks
Popular owners
Glaxo Group Limited (173) Novartis AG (130) JOHNSON & JOHNSON (127) Millennium Pharmaceuticals, Inc. (54) Eli Lilly and Company (51) Windmill Health Products, LLC (46) Bayer Aktiengesellschaft (44) SANOFI (41) Wyeth LLC (41) Pfizer Inc. (39) Forest Laboratories, Inc. (34) Bristol-Myers Squibb Company (33) Vital Health Pharmaceuticals, Inc. (31) Primary Investments Group Limited (28) S. C. Johnson & Son, Inc. (28) MERCK SHARP & DOHME CORP. (27) Futurebiotics, LLC (26) MONSTER ENERGY COMPANY (19) Scott Riddell (17) Biocept, Inc. (16)Popular publication dates
Nov. 23, 2010 Mar. 08, 2011 Mar. 15, 2011 Mar. 22, 2011 Nov. 16, 2010 Mar. 29, 2011 Apr. 19, 2011 Apr. 12, 2011 Oct. 19, 2010 Oct. 26, 2010 Apr. 26, 2011 Feb. 15, 2011 Oct. 05, 2010 Oct. 12, 2010 Jan. 25, 2011 Sep. 21, 2010 Jan. 11, 2011 Feb. 22, 2011 Sep. 28, 2010 Apr. 05, 2011Similar brands
